nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB4A—Vincristine—muscle cancer	0.0985	0.116	CbGbCtD
Ixabepilone—TUBB2B—Vincristine—muscle cancer	0.0985	0.116	CbGbCtD
Ixabepilone—TUBB8—Vincristine—muscle cancer	0.0985	0.116	CbGbCtD
Ixabepilone—TUBB6—Vincristine—muscle cancer	0.0985	0.116	CbGbCtD
Ixabepilone—TUBB2A—Vincristine—muscle cancer	0.0985	0.116	CbGbCtD
Ixabepilone—TUBB3—Vincristine—muscle cancer	0.0985	0.116	CbGbCtD
Ixabepilone—TUBB1—Vincristine—muscle cancer	0.0824	0.0973	CbGbCtD
Ixabepilone—TUBB4B—Vincristine—muscle cancer	0.0824	0.0973	CbGbCtD
Ixabepilone—TUBB—Vincristine—muscle cancer	0.0824	0.0973	CbGbCtD
Ixabepilone—CYP3A4—Vincristine—muscle cancer	0.00351	0.00415	CbGbCtD
Ixabepilone—CYP3A4—Etoposide—muscle cancer	0.00322	0.0038	CbGbCtD
Ixabepilone—CYP3A4—Doxorubicin—muscle cancer	0.0022	0.00259	CbGbCtD
Ixabepilone—TUBB8—head—muscle cancer	0.00171	0.0409	CbGeAlD
Ixabepilone—TUBB8—testis—muscle cancer	0.00166	0.0396	CbGeAlD
Ixabepilone—TUBB4A—embryo—muscle cancer	0.00141	0.0336	CbGeAlD
Ixabepilone—TUBB1—bone marrow—muscle cancer	0.00129	0.0309	CbGeAlD
Ixabepilone—TUBB3—head—muscle cancer	0.00117	0.0279	CbGeAlD
Ixabepilone—TUBB1—head—muscle cancer	0.00114	0.0273	CbGeAlD
Ixabepilone—TUBB3—testis—muscle cancer	0.00113	0.027	CbGeAlD
Ixabepilone—TUBB1—testis—muscle cancer	0.0011	0.0264	CbGeAlD
Ixabepilone—TUBB4B—embryo—muscle cancer	0.0011	0.0262	CbGeAlD
Ixabepilone—TUBB4A—renal system—muscle cancer	0.00106	0.0254	CbGeAlD
Ixabepilone—TUBB2B—renal system—muscle cancer	0.00103	0.0246	CbGeAlD
Ixabepilone—TUBB—smooth muscle tissue—muscle cancer	0.00101	0.0241	CbGeAlD
Ixabepilone—TUBB2A—smooth muscle tissue—muscle cancer	0.00101	0.024	CbGeAlD
Ixabepilone—TUBB6—smooth muscle tissue—muscle cancer	0.000991	0.0237	CbGeAlD
Ixabepilone—TUBB6—renal system—muscle cancer	0.000954	0.0228	CbGeAlD
Ixabepilone—TUBB2B—cardiac atrium—muscle cancer	0.000921	0.022	CbGeAlD
Ixabepilone—TUBB—cardiac atrium—muscle cancer	0.000871	0.0208	CbGeAlD
Ixabepilone—TUBB2A—cardiac atrium—muscle cancer	0.000867	0.0207	CbGeAlD
Ixabepilone—TUBB4B—smooth muscle tissue—muscle cancer	0.000862	0.0206	CbGeAlD
Ixabepilone—TUBB6—cardiac atrium—muscle cancer	0.000855	0.0204	CbGeAlD
Ixabepilone—TUBB4A—tendon—muscle cancer	0.00083	0.0198	CbGeAlD
Ixabepilone—TUBB4B—renal system—muscle cancer	0.00083	0.0198	CbGeAlD
Ixabepilone—TUBB2B—tendon—muscle cancer	0.000802	0.0192	CbGeAlD
Ixabepilone—TUBB—tendon—muscle cancer	0.000759	0.0181	CbGeAlD
Ixabepilone—TUBB2A—tendon—muscle cancer	0.000755	0.018	CbGeAlD
Ixabepilone—TUBB6—tendon—muscle cancer	0.000745	0.0178	CbGeAlD
Ixabepilone—TUBB2B—vagina—muscle cancer	0.000745	0.0178	CbGeAlD
Ixabepilone—TUBB4B—cardiac atrium—muscle cancer	0.000743	0.0178	CbGeAlD
Ixabepilone—TUBB—bone marrow—muscle cancer	0.000735	0.0176	CbGeAlD
Ixabepilone—TUBB2A—bone marrow—muscle cancer	0.000732	0.0175	CbGeAlD
Ixabepilone—TUBB6—bone marrow—muscle cancer	0.000722	0.0172	CbGeAlD
Ixabepilone—TUBB4A—head—muscle cancer	0.000712	0.017	CbGeAlD
Ixabepilone—TUBB—vagina—muscle cancer	0.000705	0.0168	CbGeAlD
Ixabepilone—TUBB2A—vagina—muscle cancer	0.000701	0.0167	CbGeAlD
Ixabepilone—TUBB6—vagina—muscle cancer	0.000691	0.0165	CbGeAlD
Ixabepilone—TUBB2B—head—muscle cancer	0.000688	0.0164	CbGeAlD
Ixabepilone—TUBB4A—testis—muscle cancer	0.000687	0.0164	CbGeAlD
Ixabepilone—TUBB2B—testis—muscle cancer	0.000664	0.0159	CbGeAlD
Ixabepilone—TUBB4B—tendon—muscle cancer	0.000648	0.0155	CbGeAlD
Ixabepilone—TUBB2A—head—muscle cancer	0.000647	0.0155	CbGeAlD
Ixabepilone—TUBB6—head—muscle cancer	0.000639	0.0153	CbGeAlD
Ixabepilone—TUBB—testis—muscle cancer	0.000629	0.015	CbGeAlD
Ixabepilone—TUBB4B—bone marrow—muscle cancer	0.000627	0.015	CbGeAlD
Ixabepilone—TUBB2A—testis—muscle cancer	0.000625	0.0149	CbGeAlD
Ixabepilone—TUBB6—testis—muscle cancer	0.000617	0.0147	CbGeAlD
Ixabepilone—TUBB4B—vagina—muscle cancer	0.000601	0.0144	CbGeAlD
Ixabepilone—TUBB4B—head—muscle cancer	0.000555	0.0133	CbGeAlD
Ixabepilone—TUBB4B—testis—muscle cancer	0.000536	0.0128	CbGeAlD
Ixabepilone—CYP3A4—renal system—muscle cancer	0.000341	0.00814	CbGeAlD
Ixabepilone—Infestation NOS—Etoposide—muscle cancer	0.000279	0.00251	CcSEcCtD
Ixabepilone—Infestation—Etoposide—muscle cancer	0.000279	0.00251	CcSEcCtD
Ixabepilone—Mediastinal disorder—Vincristine—muscle cancer	0.000278	0.00251	CcSEcCtD
Ixabepilone—Anaemia—Dactinomycin—muscle cancer	0.000278	0.00251	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Etoposide—muscle cancer	0.000275	0.00248	CcSEcCtD
Ixabepilone—Renal failure—Etoposide—muscle cancer	0.000274	0.00247	CcSEcCtD
Ixabepilone—Myocardial infarction—Etoposide—muscle cancer	0.000273	0.00246	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Etoposide—muscle cancer	0.000273	0.00246	CcSEcCtD
Ixabepilone—Alopecia—Vincristine—muscle cancer	0.000273	0.00246	CcSEcCtD
Ixabepilone—Jaundice—Etoposide—muscle cancer	0.000272	0.00245	CcSEcCtD
Ixabepilone—Stomatitis—Etoposide—muscle cancer	0.000272	0.00245	CcSEcCtD
Ixabepilone—Mental disorder—Vincristine—muscle cancer	0.000271	0.00244	CcSEcCtD
Ixabepilone—Leukopenia—Dactinomycin—muscle cancer	0.000269	0.00243	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Etoposide—muscle cancer	0.000264	0.00237	CcSEcCtD
Ixabepilone—Coordination abnormal—Doxorubicin—muscle cancer	0.000263	0.00237	CcSEcCtD
Ixabepilone—Musculoskeletal pain—Doxorubicin—muscle cancer	0.000262	0.00236	CcSEcCtD
Ixabepilone—Sepsis—Methotrexate—muscle cancer	0.000259	0.00233	CcSEcCtD
Ixabepilone—Myalgia—Dactinomycin—muscle cancer	0.000256	0.00231	CcSEcCtD
Ixabepilone—Hypoaesthesia—Etoposide—muscle cancer	0.000249	0.00224	CcSEcCtD
Ixabepilone—Anaemia—Vincristine—muscle cancer	0.000249	0.00224	CcSEcCtD
Ixabepilone—Colitis—Doxorubicin—muscle cancer	0.000248	0.00224	CcSEcCtD
Ixabepilone—Urinary tract disorder—Etoposide—muscle cancer	0.000247	0.00223	CcSEcCtD
Ixabepilone—Skin exfoliation—Doxorubicin—muscle cancer	0.000247	0.00222	CcSEcCtD
Ixabepilone—Oedema—Dactinomycin—muscle cancer	0.000246	0.00221	CcSEcCtD
Ixabepilone—Urethral disorder—Etoposide—muscle cancer	0.000245	0.00221	CcSEcCtD
Ixabepilone—Infection—Dactinomycin—muscle cancer	0.000244	0.0022	CcSEcCtD
Ixabepilone—Neuropathy—Doxorubicin—muscle cancer	0.000243	0.00219	CcSEcCtD
Ixabepilone—Leukopenia—Vincristine—muscle cancer	0.000241	0.00217	CcSEcCtD
Ixabepilone—Thrombocytopenia—Dactinomycin—muscle cancer	0.000241	0.00217	CcSEcCtD
Ixabepilone—Erythema multiforme—Etoposide—muscle cancer	0.000237	0.00213	CcSEcCtD
Ixabepilone—Oesophagitis—Doxorubicin—muscle cancer	0.000236	0.00213	CcSEcCtD
Ixabepilone—Anorexia—Dactinomycin—muscle cancer	0.000234	0.00211	CcSEcCtD
Ixabepilone—Eye disorder—Etoposide—muscle cancer	0.000234	0.00211	CcSEcCtD
Ixabepilone—Cardiac disorder—Etoposide—muscle cancer	0.000232	0.00209	CcSEcCtD
Ixabepilone—Myalgia—Vincristine—muscle cancer	0.000229	0.00206	CcSEcCtD
Ixabepilone—Angiopathy—Etoposide—muscle cancer	0.000227	0.00205	CcSEcCtD
Ixabepilone—Immune system disorder—Etoposide—muscle cancer	0.000226	0.00204	CcSEcCtD
Ixabepilone—Mediastinal disorder—Etoposide—muscle cancer	0.000226	0.00203	CcSEcCtD
Ixabepilone—Chills—Etoposide—muscle cancer	0.000225	0.00202	CcSEcCtD
Ixabepilone—Sepsis—Doxorubicin—muscle cancer	0.000224	0.00202	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000224	0.00202	CcSEcCtD
Ixabepilone—Alopecia—Etoposide—muscle cancer	0.000221	0.00199	CcSEcCtD
Ixabepilone—Lethargy—Methotrexate—muscle cancer	0.000221	0.00199	CcSEcCtD
Ixabepilone—Oedema—Vincristine—muscle cancer	0.00022	0.00198	CcSEcCtD
Ixabepilone—Infection—Vincristine—muscle cancer	0.000218	0.00196	CcSEcCtD
Ixabepilone—Nervous system disorder—Vincristine—muscle cancer	0.000215	0.00194	CcSEcCtD
Ixabepilone—Thrombocytopenia—Vincristine—muscle cancer	0.000215	0.00194	CcSEcCtD
Ixabepilone—Decreased appetite—Dactinomycin—muscle cancer	0.000214	0.00192	CcSEcCtD
Ixabepilone—Fatigue—Dactinomycin—muscle cancer	0.000212	0.00191	CcSEcCtD
Ixabepilone—Pain—Dactinomycin—muscle cancer	0.00021	0.00189	CcSEcCtD
Ixabepilone—Muscle spasms—Etoposide—muscle cancer	0.000209	0.00189	CcSEcCtD
Ixabepilone—Anorexia—Vincristine—muscle cancer	0.000209	0.00188	CcSEcCtD
Ixabepilone—Hypotension—Vincristine—muscle cancer	0.000205	0.00185	CcSEcCtD
Ixabepilone—Anaemia—Etoposide—muscle cancer	0.000201	0.00181	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000201	0.00181	CcSEcCtD
Ixabepilone—Hot flush—Doxorubicin—muscle cancer	0.000201	0.00181	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0002	0.0018	CcSEcCtD
Ixabepilone—Menopausal symptoms—Doxorubicin—muscle cancer	0.000199	0.00179	CcSEcCtD
Ixabepilone—Insomnia—Vincristine—muscle cancer	0.000199	0.00179	CcSEcCtD
Ixabepilone—Paraesthesia—Vincristine—muscle cancer	0.000197	0.00178	CcSEcCtD
Ixabepilone—Leukopenia—Etoposide—muscle cancer	0.000195	0.00176	CcSEcCtD
Ixabepilone—Abdominal pain—Dactinomycin—muscle cancer	0.000194	0.00175	CcSEcCtD
Ixabepilone—Body temperature increased—Dactinomycin—muscle cancer	0.000194	0.00175	CcSEcCtD
Ixabepilone—Loss of consciousness—Etoposide—muscle cancer	0.000192	0.00172	CcSEcCtD
Ixabepilone—Lethargy—Doxorubicin—muscle cancer	0.000191	0.00172	CcSEcCtD
Ixabepilone—Decreased appetite—Vincristine—muscle cancer	0.000191	0.00172	CcSEcCtD
Ixabepilone—Cough—Etoposide—muscle cancer	0.00019	0.00171	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Vincristine—muscle cancer	0.00019	0.00171	CcSEcCtD
Ixabepilone—Fatigue—Vincristine—muscle cancer	0.000189	0.0017	CcSEcCtD
Ixabepilone—Hyponatraemia—Doxorubicin—muscle cancer	0.000188	0.0017	CcSEcCtD
Ixabepilone—Pain—Vincristine—muscle cancer	0.000188	0.00169	CcSEcCtD
Ixabepilone—Constipation—Vincristine—muscle cancer	0.000188	0.00169	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000188	0.00169	CcSEcCtD
Ixabepilone—Chest pain—Etoposide—muscle cancer	0.000185	0.00167	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000184	0.00166	CcSEcCtD
Ixabepilone—Hypersensitivity—Dactinomycin—muscle cancer	0.000181	0.00163	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Vincristine—muscle cancer	0.00018	0.00162	CcSEcCtD
Ixabepilone—Pancytopenia—Methotrexate—muscle cancer	0.000178	0.0016	CcSEcCtD
Ixabepilone—Infection—Etoposide—muscle cancer	0.000177	0.00159	CcSEcCtD
Ixabepilone—Asthenia—Dactinomycin—muscle cancer	0.000176	0.00159	CcSEcCtD
Ixabepilone—Neutropenia—Methotrexate—muscle cancer	0.000175	0.00158	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—muscle cancer	0.000175	0.00157	CcSEcCtD
Ixabepilone—Thrombocytopenia—Etoposide—muscle cancer	0.000174	0.00157	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000174	0.00157	CcSEcCtD
Ixabepilone—Abdominal pain—Vincristine—muscle cancer	0.000174	0.00156	CcSEcCtD
Ixabepilone—Body temperature increased—Vincristine—muscle cancer	0.000174	0.00156	CcSEcCtD
Ixabepilone—Skin disorder—Etoposide—muscle cancer	0.000173	0.00156	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—muscle cancer	0.000171	0.00154	CcSEcCtD
Ixabepilone—Anorexia—Etoposide—muscle cancer	0.00017	0.00153	CcSEcCtD
Ixabepilone—Diarrhoea—Dactinomycin—muscle cancer	0.000168	0.00151	CcSEcCtD
Ixabepilone—Pneumonia—Methotrexate—muscle cancer	0.000168	0.00151	CcSEcCtD
Ixabepilone—Infestation NOS—Methotrexate—muscle cancer	0.000167	0.0015	CcSEcCtD
Ixabepilone—Infestation—Methotrexate—muscle cancer	0.000167	0.0015	CcSEcCtD
Ixabepilone—Hypotension—Etoposide—muscle cancer	0.000166	0.0015	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—muscle cancer	0.000166	0.0015	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—muscle cancer	0.000166	0.00149	CcSEcCtD
Ixabepilone—Renal failure—Methotrexate—muscle cancer	0.000164	0.00148	CcSEcCtD
Ixabepilone—Stomatitis—Methotrexate—muscle cancer	0.000163	0.00147	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—muscle cancer	0.000162	0.00146	CcSEcCtD
Ixabepilone—Hypersensitivity—Vincristine—muscle cancer	0.000162	0.00146	CcSEcCtD
Ixabepilone—Paraesthesia—Etoposide—muscle cancer	0.00016	0.00144	CcSEcCtD
Ixabepilone—Dyspnoea—Etoposide—muscle cancer	0.000159	0.00143	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—muscle cancer	0.000158	0.00142	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Methotrexate—muscle cancer	0.000158	0.00142	CcSEcCtD
Ixabepilone—Asthenia—Vincristine—muscle cancer	0.000157	0.00142	CcSEcCtD
Ixabepilone—Vomiting—Dactinomycin—muscle cancer	0.000156	0.00141	CcSEcCtD
Ixabepilone—Rash—Dactinomycin—muscle cancer	0.000155	0.0014	CcSEcCtD
Ixabepilone—Decreased appetite—Etoposide—muscle cancer	0.000155	0.00139	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—muscle cancer	0.000154	0.00139	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000154	0.00138	CcSEcCtD
Ixabepilone—Fatigue—Etoposide—muscle cancer	0.000153	0.00138	CcSEcCtD
Ixabepilone—Pain—Etoposide—muscle cancer	0.000152	0.00137	CcSEcCtD
Ixabepilone—Constipation—Etoposide—muscle cancer	0.000152	0.00137	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—muscle cancer	0.000152	0.00137	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000151	0.00136	CcSEcCtD
Ixabepilone—Haemoglobin—Methotrexate—muscle cancer	0.000151	0.00136	CcSEcCtD
Ixabepilone—Diarrhoea—Vincristine—muscle cancer	0.00015	0.00135	CcSEcCtD
Ixabepilone—Haemorrhage—Methotrexate—muscle cancer	0.00015	0.00135	CcSEcCtD
Ixabepilone—Urinary tract disorder—Methotrexate—muscle cancer	0.000148	0.00133	CcSEcCtD
Ixabepilone—Urethral disorder—Methotrexate—muscle cancer	0.000147	0.00132	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—muscle cancer	0.000147	0.00132	CcSEcCtD
Ixabepilone—Nausea—Dactinomycin—muscle cancer	0.000146	0.00131	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—muscle cancer	0.000145	0.00131	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Etoposide—muscle cancer	0.000145	0.00131	CcSEcCtD
Ixabepilone—Dizziness—Vincristine—muscle cancer	0.000145	0.00131	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—muscle cancer	0.000145	0.0013	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—muscle cancer	0.000145	0.0013	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—muscle cancer	0.000142	0.00128	CcSEcCtD
Ixabepilone—Erythema multiforme—Methotrexate—muscle cancer	0.000142	0.00128	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000142	0.00128	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—muscle cancer	0.000141	0.00127	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—muscle cancer	0.000141	0.00127	CcSEcCtD
Ixabepilone—Body temperature increased—Etoposide—muscle cancer	0.000141	0.00127	CcSEcCtD
Ixabepilone—Abdominal pain—Etoposide—muscle cancer	0.000141	0.00127	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—muscle cancer	0.000141	0.00127	CcSEcCtD
Ixabepilone—Eye disorder—Methotrexate—muscle cancer	0.00014	0.00126	CcSEcCtD
Ixabepilone—Vomiting—Vincristine—muscle cancer	0.00014	0.00126	CcSEcCtD
Ixabepilone—Cardiac disorder—Methotrexate—muscle cancer	0.000139	0.00125	CcSEcCtD
Ixabepilone—Rash—Vincristine—muscle cancer	0.000138	0.00125	CcSEcCtD
Ixabepilone—Dermatitis—Vincristine—muscle cancer	0.000138	0.00125	CcSEcCtD
Ixabepilone—Headache—Vincristine—muscle cancer	0.000138	0.00124	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000137	0.00123	CcSEcCtD
Ixabepilone—Angiopathy—Methotrexate—muscle cancer	0.000136	0.00122	CcSEcCtD
Ixabepilone—Immune system disorder—Methotrexate—muscle cancer	0.000135	0.00122	CcSEcCtD
Ixabepilone—Mediastinal disorder—Methotrexate—muscle cancer	0.000135	0.00122	CcSEcCtD
Ixabepilone—Chills—Methotrexate—muscle cancer	0.000135	0.00121	CcSEcCtD
Ixabepilone—Alopecia—Methotrexate—muscle cancer	0.000132	0.00119	CcSEcCtD
Ixabepilone—Mental disorder—Methotrexate—muscle cancer	0.000131	0.00118	CcSEcCtD
Ixabepilone—Hypersensitivity—Etoposide—muscle cancer	0.000131	0.00118	CcSEcCtD
Ixabepilone—Malnutrition—Methotrexate—muscle cancer	0.000131	0.00118	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—muscle cancer	0.00013	0.00118	CcSEcCtD
Ixabepilone—Nausea—Vincristine—muscle cancer	0.00013	0.00117	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—muscle cancer	0.00013	0.00117	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000129	0.00116	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—muscle cancer	0.000128	0.00115	CcSEcCtD
Ixabepilone—Asthenia—Etoposide—muscle cancer	0.000128	0.00115	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—muscle cancer	0.000128	0.00115	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—muscle cancer	0.000127	0.00115	CcSEcCtD
Ixabepilone—Pruritus—Etoposide—muscle cancer	0.000126	0.00113	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—muscle cancer	0.000123	0.00111	CcSEcCtD
Ixabepilone—Diarrhoea—Etoposide—muscle cancer	0.000122	0.0011	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—muscle cancer	0.000121	0.00109	CcSEcCtD
Ixabepilone—Anaemia—Methotrexate—muscle cancer	0.000121	0.00109	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—muscle cancer	0.00012	0.00109	CcSEcCtD
Ixabepilone—Angiopathy—Doxorubicin—muscle cancer	0.000118	0.00106	CcSEcCtD
Ixabepilone—Dizziness—Etoposide—muscle cancer	0.000118	0.00106	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—muscle cancer	0.000117	0.00106	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—muscle cancer	0.000117	0.00105	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—muscle cancer	0.000117	0.00105	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—muscle cancer	0.000116	0.00105	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—muscle cancer	0.000115	0.00103	CcSEcCtD
Ixabepilone—Cough—Methotrexate—muscle cancer	0.000114	0.00103	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—muscle cancer	0.000114	0.00102	CcSEcCtD
Ixabepilone—Vomiting—Etoposide—muscle cancer	0.000113	0.00102	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—muscle cancer	0.000113	0.00102	CcSEcCtD
Ixabepilone—Rash—Etoposide—muscle cancer	0.000112	0.00101	CcSEcCtD
Ixabepilone—Dermatitis—Etoposide—muscle cancer	0.000112	0.00101	CcSEcCtD
Ixabepilone—Headache—Etoposide—muscle cancer	0.000111	0.001	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—muscle cancer	0.000111	0.001	CcSEcCtD
Ixabepilone—Chest pain—Methotrexate—muscle cancer	0.000111	0.001	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—muscle cancer	0.000111	0.001	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00011	0.000994	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—muscle cancer	0.000109	0.000978	CcSEcCtD
Ixabepilone—Infection—Methotrexate—muscle cancer	0.000106	0.000953	CcSEcCtD
Ixabepilone—Nausea—Etoposide—muscle cancer	0.000106	0.000951	CcSEcCtD
Ixabepilone—Nervous system disorder—Methotrexate—muscle cancer	0.000104	0.000941	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—muscle cancer	0.000104	0.000941	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—muscle cancer	0.000104	0.000939	CcSEcCtD
Ixabepilone—Skin disorder—Methotrexate—muscle cancer	0.000103	0.000932	CcSEcCtD
Ixabepilone—Anorexia—Methotrexate—muscle cancer	0.000102	0.000914	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—muscle cancer	0.000101	0.000913	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—muscle cancer	0.000101	0.000911	CcSEcCtD
Ixabepilone—Hypotension—Methotrexate—muscle cancer	9.95e-05	0.000896	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—muscle cancer	9.93e-05	0.000895	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—muscle cancer	9.86e-05	0.000888	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—muscle cancer	9.7e-05	0.000874	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—muscle cancer	9.63e-05	0.000868	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—muscle cancer	9.62e-05	0.000866	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—muscle cancer	9.62e-05	0.000866	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—muscle cancer	9.62e-05	0.000866	CcSEcCtD
Ixabepilone—Paraesthesia—Methotrexate—muscle cancer	9.56e-05	0.000861	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	9.55e-05	0.00086	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—muscle cancer	9.5e-05	0.000855	CcSEcCtD
Ixabepilone—Decreased appetite—Methotrexate—muscle cancer	9.26e-05	0.000834	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—muscle cancer	9.22e-05	0.000831	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Methotrexate—muscle cancer	9.2e-05	0.000828	CcSEcCtD
Ixabepilone—Fatigue—Methotrexate—muscle cancer	9.18e-05	0.000827	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—muscle cancer	9.16e-05	0.000825	CcSEcCtD
Ixabepilone—Pain—Methotrexate—muscle cancer	9.11e-05	0.00082	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—muscle cancer	9.07e-05	0.000817	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—muscle cancer	9.04e-05	0.000815	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—muscle cancer	9.03e-05	0.000813	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—muscle cancer	8.96e-05	0.000807	CcSEcCtD
Ixabepilone—Anorexia—Doxorubicin—muscle cancer	8.79e-05	0.000792	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Methotrexate—muscle cancer	8.71e-05	0.000784	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—muscle cancer	8.62e-05	0.000776	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—muscle cancer	8.42e-05	0.000758	CcSEcCtD
Ixabepilone—Abdominal pain—Methotrexate—muscle cancer	8.42e-05	0.000758	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	8.4e-05	0.000757	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—muscle cancer	8.34e-05	0.000751	CcSEcCtD
Ixabepilone—Paraesthesia—Doxorubicin—muscle cancer	8.28e-05	0.000746	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—muscle cancer	8.22e-05	0.000741	CcSEcCtD
Ixabepilone—Decreased appetite—Doxorubicin—muscle cancer	8.02e-05	0.000722	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—muscle cancer	7.96e-05	0.000717	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—muscle cancer	7.95e-05	0.000716	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—muscle cancer	7.89e-05	0.00071	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—muscle cancer	7.89e-05	0.00071	CcSEcCtD
Ixabepilone—Hypersensitivity—Methotrexate—muscle cancer	7.85e-05	0.000707	CcSEcCtD
Ixabepilone—Asthenia—Methotrexate—muscle cancer	7.64e-05	0.000688	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Doxorubicin—muscle cancer	7.54e-05	0.000679	CcSEcCtD
Ixabepilone—Pruritus—Methotrexate—muscle cancer	7.54e-05	0.000679	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—muscle cancer	7.29e-05	0.000657	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—muscle cancer	7.29e-05	0.000657	CcSEcCtD
Ixabepilone—Diarrhoea—Methotrexate—muscle cancer	7.29e-05	0.000656	CcSEcCtD
Ixabepilone—Dizziness—Methotrexate—muscle cancer	7.04e-05	0.000634	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—muscle cancer	6.8e-05	0.000612	CcSEcCtD
Ixabepilone—Vomiting—Methotrexate—muscle cancer	6.77e-05	0.00061	CcSEcCtD
Ixabepilone—Rash—Methotrexate—muscle cancer	6.72e-05	0.000605	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—muscle cancer	6.71e-05	0.000604	CcSEcCtD
Ixabepilone—Headache—Methotrexate—muscle cancer	6.67e-05	0.000601	CcSEcCtD
Ixabepilone—Asthenia—Doxorubicin—muscle cancer	6.62e-05	0.000596	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—muscle cancer	6.53e-05	0.000588	CcSEcCtD
Ixabepilone—Nausea—Methotrexate—muscle cancer	6.33e-05	0.00057	CcSEcCtD
Ixabepilone—Diarrhoea—Doxorubicin—muscle cancer	6.31e-05	0.000568	CcSEcCtD
Ixabepilone—Dizziness—Doxorubicin—muscle cancer	6.1e-05	0.000549	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—muscle cancer	5.86e-05	0.000528	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—muscle cancer	5.82e-05	0.000524	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—muscle cancer	5.81e-05	0.000523	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—muscle cancer	5.78e-05	0.00052	CcSEcCtD
Ixabepilone—Nausea—Doxorubicin—muscle cancer	5.48e-05	0.000493	CcSEcCtD
